Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hadean Ventures is a European venture capital firm established in 2014, focusing on the life sciences sector. Headquartered in Oslo, Norway, the firm also operates an office at the Karolinska Institute Science Park in Stockholm, Sweden. Hadean Ventures manages approximately €230 million in assets, emphasizing investments in innovative healthcare solutions that address significant medical needs.
The firm has developed a strong reputation within the Nordic life science ecosystem, collaborating closely with academic institutions to enhance its investment strategy. Hadean Ventures has successfully built a diverse portfolio, supporting companies across various healthcare verticals and stages of development. The firm’s commitment to addressing unmet medical needs drives its investment decisions, ensuring that it backs products with the potential to make a meaningful impact in the healthcare landscape.
Hadean Ventures invests primarily in the healthcare sector, with a focus on life sciences, including therapeutics, diagnostics, medtech, and digital health technologies. The firm targets companies at various stages, from pre-seed to growth equity, allowing it to engage with startups as they evolve. Hadean Ventures emphasizes investments that align with strong environmental, social, and governance (ESG) principles, ensuring that its portfolio companies not only drive financial returns but also contribute positively to society.
The firm seeks innovative products that address significant medical needs, leveraging its extensive network in the Nordic life science sector to support portfolio companies. Hadean Ventures is particularly interested in collaborations with academic institutions, which can enhance the development and commercialization of healthcare solutions. This strategic approach enables the firm to identify and invest in promising startups that have the potential to transform the healthcare landscape.
Hadean Ventures has built a diverse portfolio of 19 companies, focusing on innovative healthcare solutions. Notable portfolio companies include:
This portfolio reflects Hadean Ventures' commitment to supporting innovative healthcare solutions that address unmet medical needs across Europe.
Ingrid Teigland Akay: Managing Partner with extensive experience in venture capital and life sciences. She has a strong background in supporting healthcare startups and has been instrumental in Hadean's growth.
Walter Stockinger: Managing Partner who brings a wealth of knowledge in investment strategies and portfolio management. He has a proven track record in the life sciences sector.
Roger Franklin, PhD: Partner based in Stockholm, affiliated with the Karolinska Institute. He has a strong academic background and expertise in biopharmaceuticals.
Nora Kaarela: Venture Partner with experience in healthcare investments and a focus on supporting early-stage companies.
Florian Eckhardt: Senior Advisor with a background in life sciences and investment management, providing strategic insights to portfolio companies.
Silje Ervik: Head of Legal, ensuring compliance and legal support for Hadean's investments.
Diar Tahir: Financial Controller responsible for managing financial operations and reporting.
Markus Dietrich: Senior Investment Associate with a focus on sourcing and evaluating investment opportunities.
Georgina Askeland: Principal involved in deal sourcing and portfolio management.
Miao He: Senior Investment Associate contributing to investment analysis and due diligence.
Dustin Zielinski: Investment Analyst supporting the investment team with research and analysis.
To pitch Hadean Ventures, founders should use the online pitch portal available at hadeanventures.com/pitch. The pitch deck should include a concise overview of the product, market opportunity, competitive landscape, and team qualifications. Hadean Ventures prefers well-structured decks that clearly outline the business model and financial projections.
Response times can vary, but founders can generally expect feedback within a few weeks. Warm introductions are beneficial, particularly from individuals within Hadean's network or the life sciences community.
Hadean Ventures hosts annual events aimed at connecting with stakeholders and showcasing its portfolio companies. These events take place in various locations, including Oslo and Stockholm, providing a platform for startups to present their innovations to potential investors and partners.
Additionally, the firm engages in collaborative initiatives with academic institutions, particularly the Karolinska Institute, to foster innovation and support the development of healthcare solutions.
In December 2023, Hadean Ventures closed its second fund, Hadean Capital II, at €144 million, exceeding its target of €125 million. This fund will continue to focus on the life sciences sector, supporting innovative healthcare solutions.
Recent investments include notable companies such as Alex Therapeutics and Arthex Biotech, which align with Hadean's thesis of addressing unmet medical needs. The firm has also been active in co-leading rounds for companies like Neuro Event Labs and SAGA Diagnostics, further solidifying its presence in the healthcare investment landscape.
What are Hadean Ventures' investment criteria?
Hadean Ventures focuses on the healthcare sector, investing in therapeutics, diagnostics, medtech, and digital health technologies. The firm targets companies at various stages, from pre-seed to growth equity, emphasizing innovative products that address significant medical needs.
How can I pitch to Hadean Ventures?
Founders can pitch to Hadean Ventures through their online pitch portal at hadeanventures.com/pitch. It is recommended to include a clear overview of the product, market opportunity, and team background in the pitch deck.
What makes Hadean Ventures different from other VCs?
Hadean Ventures distinguishes itself through its strong network in the Nordic life science ecosystem and its collaboration with academic institutions like the Karolinska Institute. This enables the firm to provide strategic guidance and support to its portfolio companies.
What is the geographic scope of Hadean Ventures?
The firm primarily invests in Europe, with a particular emphasis on the Nordic countries and German-speaking regions (DACH).
What is the typical check size for investments?
Hadean Ventures invests across various stages, with check sizes varying depending on the stage of the company and the specific investment opportunity.
What kind of post-investment support does Hadean Ventures provide?
Hadean Ventures adds value through strategic guidance, leveraging its extensive network, and fostering collaborations with academic institutions to help portfolio companies navigate the complexities of the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.